Trials / Completed
CompletedNCT04436393
Guardant360® Related Clinical Outcomes in Patients Who Share Medical Records-Breast Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 109 (actual)
- Sponsor
- Guardant Health, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to observe the routine clinical care of patients who have been diagnosed with breast cancer and have undergone Guardant360 testing.
Detailed description
Patients who have been diagnosed with breast cancer and have undergone Guardant360 testing will be approached regarding participation in the study. After being informed about the study and potential risks, all patients providing informed consent and access to their medical records, will provide a list of their health care providers related to their cancer treatment. Data related to their routine clinical care will be abstracted from medical records.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Guardant360 test | tumor cfDNA testing |
Timeline
- Start date
- 2020-07-02
- Primary completion
- 2022-03-17
- Completion
- 2022-03-17
- First posted
- 2020-06-18
- Last updated
- 2022-06-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04436393. Inclusion in this directory is not an endorsement.